NIH #4R01CA271237-04
Dynamic imaging and tissue biomarker models to delineate indolent from aggressive breast calcifications
- Amount
- $802K
- Period
- 2022-09-15 → 2027-08-31
- PIs
- 2
- Est. capacity / PI
- ~1 students
Ovarian cancer diagnosis and treatment · Reproductive Medicine
42 total · 1 active
NIH #4R01CA271237-04
NIH #5R01CA271237-03
NIH #1U2CCA233254-01
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
Transcriptomic subtypes in high-grade serous ovarian cancer are driven by tumor cellular composition
bioRxiv (Cold Spring Harbor Laboratory) · 2026-04-21 · 1 citations
Cancer Cell · 2026-04-16 · 1 citations
Spatial proteomics of breast ductal carcinoma in situ reveal distinct regional differences
Scientific Reports · 2026-03-13
2025-12-15